- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 231/38 - Atomes d'azote
Détention brevets de la classe C07D 231/38
Brevets de cette classe: 515
Historique des publications depuis 10 ans
|
33
|
41
|
30
|
47
|
33
|
24
|
39
|
32
|
24
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Loxo Oncology, Inc. | 84 |
17 |
| FMC Corporation | 810 |
14 |
| Novartis AG | 10173 |
12 |
| Bayer Cropscience AG | 1836 |
9 |
| Mereo Biopharma 1 Limited | 24 |
8 |
| Hua Medicine (Shanghai) Ltd. | 54 |
8 |
| Novartis Pharma AG | 275 |
7 |
| E. I. du Pont de Nemours and Company | 3486 |
7 |
| Boehringer Ingelheim International GmbH | 4486 |
7 |
| Bayer Pharma AG | 1009 |
7 |
| Assembly Biosciences, Inc. | 103 |
7 |
| Epigen Biosciences, Inc. | 13 |
7 |
| Nodthera Limited | 43 |
7 |
| FUJIFILM Corporation | 30594 |
6 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 779 |
6 |
| The Government of the United States of America, as represented by the Secretary of the Navy | 1455 |
6 |
| Shionogi & Co., Ltd. | 883 |
6 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3010 |
6 |
| Vanderbilt University | 2028 |
6 |
| The Trustees of the University of Pennsylvania | 4423 |
5 |
| Autres propriétaires | 357 |